{"changes":[{"companyHref":"/c/artiambio-net","date":"2026-10-17","documentUrl":"https://www.sbir.gov/portfolio/1703505","domain":"artiambio.net","fact":"company:added","name":"ARTIAM BIO INC.","new":"added","old":"","publisher":"SBIR.gov","reason":null,"retrievedAt":"2026-10-17","slug":"artiambio-net","status":"sourced","url":"https://whoraisedwhat.com/c/artiambio-net"}],"country":"US","description":"Artiam Bio, Inc. is a biotechnology company developing refined type 1 cannabinoid receptor (CB1) antagonists to treat significant diseases.","domain":"artiambio.net","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"unknown","investors":[],"lat":null,"lng":null,"location":null,"name":"ARTIAM BIO INC.","nameSource":{"publisher":"SBIR.gov","retrievedAt":"2026-10-17","status":"sourced","url":"https://www.sbir.gov/portfolio/1703505"},"people":[],"rounds":[],"slug":"artiambio-net","sources":[{"fact":"existence","publisher":"SBIR.gov","retrievedAt":"2026-10-17","status":"sourced","url":"https://www.sbir.gov/portfolio/1703505"},{"fact":"description","publisher":"Company website","retrievedAt":"2026-10-17","status":"sourced","url":"https://www.artiambio.net/"}],"stage":null,"techStack":[],"totalRaisedUsd":null,"updatedAt":"2026-10-17"}